Evidence map›Paper›PMID 41431600›Full record

ArticleAmerican journal of preventive cardiology2025

Accelerating evidence generation to implementation: Establishment of the Leading Awareness to Action through Implementation of Cardiometabolic Efforts (LATTICE) consortium.

Laney K Jones, Ty J Gluckman, Ankeet S Bhatt, Leandro Boer, Marc P Bonaca, Gemme Campbell-Salome, Erica Davis, Nihar R Desai, Jyothis George, Lisa Head and 8 more

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Laney K JonesAmgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA.
Ty J GluckmanProvidence Heart Institute, Providence Health System, Portland, OR, USA.
Ankeet S BhattKaiser Permanente Northern California, Oakland, CA, USA.
Leandro BoerAmgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA.
Marc P BonacaCPC Clinical Research, University of Colorado School of Medicine, Denver, CO, USA.
Gemme Campbell-SalomeAmgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA.
Erica DavisAmgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA.
Nihar R DesaiYale School of Medicine, New Haven, CT, USA.
Jyothis GeorgeAmgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA.
Lisa HeadAmgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA.
Francoise A MarvelJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Marc PennSumma Cardiovascular Institute, Akron, OH, USA.
Eric D PetersonUT Southwestern Medicine Center, Department of Medicine, Division of Cardiology, TX, USA.
Benjamin M SciricaBrigham and Women's Hospital and Harvard School of Medicine, Boston, MA, USA.
Nishant P ShahDuke University School of Medicine, Durham, NC, USA.
Katherine WilemonFamily Heart Foundation, Fernandina Beach, FL, USA.
Bethany A KalichAmgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA.
Seth S MartinJohns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent scientific advancements have led to the availability of innovative therapies to reduce the risk of cardiometabolic events, offering new tools to address the world's leading cause of mortality. The length of time from evidence generation to implementation in healthcare settings remains far from optimal, resulting in missed opportunities to improve morbidity and mortality and unrealized population-level benefit. Established in 2023, the Leading Awareness to Action through Implementation of Cardiometabolic Efforts (LATTICE™) consortium's mission is to unite partners dedicated to improving cardiometabolic health by creating an inclusive platform for sharing evidence-based tools, methodologies, and strategies to address gaps in care at scale. The LATTICE consortium aims to accomplish this by 1) exploring novel strategies for translating evidence-based advancements across diverse clinical practice settings and 2) disseminating successful strategies through a unique collaboration among clinicians, healthcare systems, payors, patients, patient advocacy groups, and life science companies. The LATTICE consortium is prioritizing projects that rigorously test strategies grounded in implementation science and hold significant promise for uptake at scale. Success of the LATTICE consortium will be assessed through improved awareness, access, and implementation of effective, scalable, and sustainable health care strategies that address cardiometabolic gaps in care.

Indexed as

CardiometabolicConsortiumImplementation science

Identifiers

PMID41431600
PMCPMC12718180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.